INCOME STATEMENT
Senores Pharmaceuticals Ltd.
BSE
Jul 16
617.55
-10.30 ( -1.64%)
Volume
8366
Prev. Close
627.85
Open Price
626.60
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 16
616.95
-10.95 ( -1.74%)
Volume
155283
Prev. Close
627.90
Open Price
630.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE0RB801010
|
Market Cap. ( ₹ in Cr. )
|
2841.28
|
P/BV
|
9.34
|
Book Value ( ₹ )
|
66.07
|
|
BSE Code
|
544319
|
52 Week High/Low ( ₹ )
|
665/435
|
FV/ML
|
10/1
|
P/E(X)
|
48.52
|
|
NSE Code
|
SENORESEQ
|
Book Closure
|
|
EPS ( ₹ )
|
12.72
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 38.54 | 33.91 | 12.37 | 15.85 | 7.91 |
| Other Operating Revenues | 0.00 | 0.10 | 0.01 | 0.00 | 0.00 |
| Total Operating Revenues | 38.54 | 34.01 | 12.38 | 15.85 | 7.91 |
| | | | | | |
| Other Income | 21.99 | 6.85 | 6.79 | 1.04 | 0.15 |
| Total Revenue | 60.53 | 40.85 | 19.17 | 16.89 | 8.06 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 7.26 | 5.66 | 0.35 | 0.00 | 3.21 |
| Purchase Of Stock-In Trade | 14.67 | 14.08 | 6.00 | 10.60 | 0.74 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -4.10 | -0.39 | -0.48 | 0.00 | 0.05 |
| Employee Benefit Expenses | 18.25 | 9.35 | 5.02 | 2.85 | 1.63 |
| Finance Costs | 6.52 | 2.71 | 2.14 | 0.49 | 0.20 |
| Depreciation And Amortisation Expenses | 3.08 | 2.04 | 0.93 | 0.58 | 0.57 |
| Other Expenses | 9.74 | 5.38 | 3.27 | 1.46 | 1.28 |
| Total Expenses | 55.42 | 38.82 | 17.23 | 15.99 | 7.66 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.11 | 2.04 | 1.94 | 0.90 | 0.40 |
| | | | | | |
| Profit/Loss Before Tax | 5.11 | 2.04 | 1.94 | 0.90 | 0.40 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1.42 | 1.36 | 0.35 | 0.19 | 0.01 |
| Deferred Tax | 0.00 | -0.14 | 0.39 | 0.42 | -0.45 |
| Total Tax Expenses | 1.42 | 1.22 | 0.74 | 0.61 | -0.44 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 3.69 | 0.81 | 1.20 | 0.29 | 0.84 |
| | | | | | |
| Profit/Loss From Continuing Operations | 3.69 | 0.81 | 1.20 | 0.29 | 0.84 |
| | | | | | |
| Profit/Loss For The Period | 3.69 | 0.81 | 1.20 | 0.29 | 0.84 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 1.02 | 0.35 | 1.26 | 0.53 | 4.07 |
| Diluted EPS (Rs.) | 1.02 | 0.32 | 0.95 | 0.53 | 4.07 |